# TM4SF19

## Overview
TM4SF19, or transmembrane 4 L six family member 19, is a gene that encodes a protein belonging to the tetraspanin family, characterized by four transmembrane domains. The TM4SF19 protein is primarily localized to the lysosomal membrane and plays a crucial role in regulating lysosomal activity, particularly in macrophages. It interacts with ATP6V0B, a component of the vacuolar H+-ATPase (V-ATPase) complex, to modulate lysosomal acidification and macrophage function. This regulation is significant for processes such as efferocytosis and lipid handling, impacting systemic metabolic functions and inflammation. TM4SF19's expression is notably upregulated in the adipose tissue of obese individuals, linking it to obesity-induced inflammation and metabolic dysfunction. Consequently, TM4SF19 is considered a potential therapeutic target for conditions related to inflammation and metabolic disorders (Choi2024TM4SF19mediated; lee2023TM4SF19mediated).

## Structure
TM4SF19, or transmembrane 4 L six family member 19, is a protein that belongs to the tetraspanin family, which is characterized by the presence of four transmembrane domains. These domains contribute to the protein's ability to span the cellular membrane multiple times, a common feature among tetraspanins. TM4SF19 typically has two extracellular loops, which are crucial for its role in cellular processes such as signal transduction and cell adhesion. 

The protein is involved in forming tetraspanin-enriched microdomains, which are specialized areas of the cell membrane that facilitate interactions with other proteins and cellular components. Post-translational modifications, such as glycosylation and palmitoylation, are prevalent in the tetraspanin family and are likely to influence the function and interactions of TM4SF19. These modifications can affect the protein's stability, localization, and ability to interact with other molecules, although specific details for TM4SF19 are not provided in the context. 

The structural characteristics of TM4SF19, including its transmembrane domains and extracellular loops, are integral to its function within the cell, although detailed information on its primary, secondary, tertiary, and quaternary structures is not available in the provided context.

## Function
TM4SF19, a lysosomal membrane protein, plays a significant role in regulating lysosomal activity by interacting with ATP6V0B, a component of the V-ATPase complex. This interaction inhibits the assembly of the V1-V0 holoenzyme, leading to reduced lysosomal acidification and affecting lysosomal function (Choi2024TM4SF19mediated; lee2023TM4SF19mediated). TM4SF19 is primarily expressed in macrophages, particularly in a subpopulation known as TREM2+ macrophages, which are involved in lipid handling and immune processes (Choi2024TM4SF19mediated; lee2023TM4SF19mediated).

In healthy cells, TM4SF19's regulation of lysosomal activity influences various cellular processes, including macrophage efferocytosis, which is the clearance of dead cells. This function is crucial for maintaining tissue homeostasis and preventing inflammation (lee2023TM4SF19mediated). TM4SF19's activity in macrophages also affects systemic metabolic functions, as its knockout has been shown to improve insulin sensitivity and glucose tolerance in high-fat diet conditions, suggesting its role in metabolic regulation (Choi2024TM4SF19mediated). The protein's involvement in these processes highlights its potential as a therapeutic target for conditions related to inflammation and metabolic dysfunction (lee2023TM4SF19mediated).

## Clinical Significance
The TM4SF19 gene is implicated in obesity-induced inflammation and metabolic dysfunction, particularly in adipose tissue macrophages. Alterations in its expression are associated with increased inflammation and metabolic issues in obesity. TM4SF19 is upregulated in the adipose tissue of obese individuals, contributing to metabolic dysfunction by affecting immune and inflammatory responses (Choi2024TM4SF19mediated; lee2023TM4SF19mediated). Knockout studies in mice have shown that the absence of TM4SF19 leads to reduced weight gain, improved glucose and insulin tolerance, and decreased hyperinsulinemia and hyperlipidemia during high-fat diet feeding. These effects are attributed to increased energy expenditure and enhanced mitochondrial biogenesis and oxidative phosphorylation (Choi2024TM4SF19mediated; lee2023TM4SF19mediated).

TM4SF19 also plays a role in regulating lysosomal activity in macrophages, impacting the clearance of dying adipocytes and reducing obesity-induced inflammation. This regulation is crucial for maintaining tissue homeostasis and resolving inflammation, suggesting that TM4SF19 could be a therapeutic target for obesity-related metabolic disorders (Choi2024TM4SF19mediated). The gene's involvement in lipid handling and immune response highlights its potential clinical significance in managing obesity-associated conditions (lee2023TM4SF19mediated).

## Interactions
TM4SF19, a lysosomal membrane protein, interacts with ATP6V0B, a subunit of the vacuolar H+-ATPase (V-ATPase) complex. This interaction inhibits V-ATPase activity by interfering with the association of its V1 and V0 domains, which is crucial for lysosomal acidification and macrophage activation. The inhibition of V-ATPase activity by TM4SF19 affects macrophage efferocytosis, contributing to obesity-induced inflammation in adipose tissue (lee2023TM4SF19mediated).

In TM4SF19 knockout (KO) mice, the loss of TM4SF19 enhances V-ATPase activities by promoting V0-V1 assembly, which increases phagocytic activity and lipid clearance. This suggests that TM4SF19 plays a regulatory role in lysosomal function and macrophage-mediated processes (lee2023TM4SF19mediated).

The study of TM4SF19 also involves the use of immunoprecipitation techniques to explore protein interactions, specifically using Myc-tagged TM4SF19 to study its interactions with other proteins. This approach helps to elucidate the molecular mechanisms by which TM4SF19 influences macrophage function and inflammation (lee2023TM4SF19mediated).


## References


[1. (Choi2024TM4SF19mediated) Cheoljun Choi, Yujin L. Jeong, Koung-Min Park, Minji Kim, Sangseob Kim, Honghyun Jo, Sumin Lee, Heeseong Kim, Garam Choi, Yoon Ha Choi, Je Kyung Seong, Sik Namgoong, Yeonseok Chung, Young-Suk Jung, James G. Granneman, Young-Min Hyun, Jong Kyoung Kim, and Yun-Hee Lee. Tm4sf19-mediated control of lysosomal activity in macrophages contributes to obesity-induced inflammation and metabolic dysfunction. Nature Communications, March 2024. URL: http://dx.doi.org/10.1038/s41467-024-47108-8, doi:10.1038/s41467-024-47108-8. This article has 1 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-47108-8)

2. (lee2023TM4SF19mediated) TM4SF19-mediated brake of macrophage efferocytosis contributes to obesity-induced inflammation of adipose tissue. This article has 0 citations.